{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:47:02Z","timestamp":1781639222482,"version":"3.54.5"},"reference-count":123,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2021-596"],"award-info":[{"award-number":["075-15-2021-596"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["21-15-00339"],"award-info":[{"award-number":["21-15-00339"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRCEP"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The number of patients with functional loss of bone and cartilage tissue has shown an increasing\ntrend. Insufficient or inappropriate conventional treatments applied for trauma, orthopedic\ndiseases, or other bone and cartilage-related disorders can lead to bone and cartilage damage. This\nrepresents a worldwide public health issue and a significant economic burden. Advanced therapeutic\nmedicinal products (ATMPs) proposed promising alternative therapeutic modalities by application\nof cell-based and tissue engineering approaches. Recently, several ATMPs have been developed\nto promote bone and cartilage tissue regeneration. Fifteen ATMPs, two related to bone and 13\nrelated to cartilage, have received regulatory approval and marketing authorization. However, four\nATMPs were withdrawn from the market for various reasons. However, ATMPs that are still on the\nmarket have demonstrated positive results, their broad application faced limitations. The development\nand standardization of methodologies will be a major challenge in the coming decades. Currently,\nthe number of ATMPs in clinical trials using mesenchymal stromal cells or chondrocytes indicates\na growing recognition that current ATMPs can be improved. Research on bone and cartilage\ntissue regeneration continues to expand. Cell-based therapies are likely to be clinically supported by\nthe new ATMPs, innovative fabrication processes, and enhanced surgical approaches. In this study,\nwe highlighted the available ATMPs that have been used in bone and cartilage defects and discussed\ntheir advantages and disadvantages in clinical applications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0127724328274436231207062008","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T15:25:56Z","timestamp":1706196356000},"page":"355-369","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Advanced Therapeutic Medicinal Products in Bone and Cartilage Defects"],"prefix":"10.2174","volume":"19","author":[{"given":"Dylana","family":"Diaz-Solano","sequence":"first","affiliation":[{"name":"Unidad de Terapia Celular - Laboratorio de Patolog\u00eda Celular y Molecular, Centro de Medicina Regenerativa,\nInstituto Venezolano de Investigaciones Cient\u00edficas (IVIC), Caracas, Venezuela"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Sadri","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine,\nCell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Peshkova","sequence":"additional","affiliation":[{"name":"Institute for Regenerative Medicine, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Shpichka","sequence":"additional","affiliation":[{"name":"Institute for Regenerative Medicine, Sechenov University, Moscow, Russia"},{"name":"Chemistry Department, Lomonosov Moscow\nState University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Smirnova","sequence":"additional","affiliation":[{"name":"Institute for Regenerative Medicine, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshanak","family":"Shams","sequence":"additional","affiliation":[{"name":"Bone and Joint Reconstruction Research Center, Department of Orthopedics,\nSchool of Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Timashev","sequence":"additional","affiliation":[{"name":"Institute for Regenerative Medicine, Sechenov University, Moscow, Russia"},{"name":"World-Class Research Center \u201cDigital Biodesign\nand Personalized Healthcare\u201d, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Vosough","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine,\nCell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","volume":"15","author":"Borgstr\u00f6m F.","year":"2020","unstructured":"Borgstr\u00f6m F.; Karlsson L.; Orts\u00e4ter G.; Fragility fractures in Europe: Burden, management and opportunities. Arch Osteoporos  2020,15(1),59","journal-title":"Arch Osteoporos"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/jbmr.3640","volume":"34","author":"Tatangelo G.","year":"2019","unstructured":"Tatangelo G.; Watts J.; Lim K.; The cost of osteoporosis, osteopenia, and associated fractures in Australia in 2017: Cost of osteoporosis, osteopenia, and fractures. J Bone Miner Res  2019,34(4),616-625","journal-title":"J Bone Miner Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1007\/s00198-017-4153-6","volume":"28","author":"Williamson S.","year":"2017","unstructured":"Williamson S.; Landeiro F.; McConnell T.; Costs of fragility hip fractures globally: A systematic review and meta-regression analysis. Osteoporos Int  2017,28(10),2791-2800","journal-title":"Osteoporos Int"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.aap.2016.04.003","volume":"93","author":"Polinder S.","year":"2016","unstructured":"Polinder S.; Haagsma J.; Panneman M.; Scholten A.; Brugmans M.; Van Beeck E.; The economic burden of injury: Health care and productivity costs of injuries in the Netherlands. Accid Anal Prev  2016,93,92-100","journal-title":"Accid Anal Prev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1302\/0301-620X.89B4.18301","volume":"89-B","author":"Little D.G.","year":"2007","unstructured":"Little D.G.; Ramachandran M.; Schindeler A.; The anabolic and catabolic responses in bone repair. J Bone Joint Surg Br  2007,89-B(4),425-433","journal-title":"J Bone Joint Surg Br"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/jbm.a.35556","volume":"104","author":"Yan H.","year":"2016","unstructured":"Yan H.; Liu X.; Zhu M.; Hybrid use of combined and sequential delivery of growth factors and ultrasound stimulation in porous multilayer composite scaffolds to promote both vascularization and bone formation in bone tissue engineering. J Biomed Mater Res A  2016,104(1),195-208","journal-title":"J Biomed Mater Res A"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1749-799X-9-18","volume":"9","author":"Oryan A.","year":"2014","unstructured":"Oryan A.; Alidadi S.; Moshiri A.; Maffulli N.; Bone regenerative medicine: Classic options, novel strategies, and future directions. J Orthop Surg Res  2014,9(1),18","journal-title":"J Orthop Surg Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.injury.2011.06.011","volume":"42","author":"Calori G.M.","year":"2011","unstructured":"Calori G.M.; Mazza E.; Colombo M.; Ripamonti C.; The use of bone-graft substitutes in large bone defects: Any specific needs? Injury  2011,42(S2),S56-S63","journal-title":"Injury"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1582-4934.2010.01224.x","volume":"15","author":"Arvidson K.","year":"2011","unstructured":"Arvidson K.; Abdallah B.M.; Applegate L.A.; Bone regeneration and stem cells. J Cell Mol Med  2011,15(4),718-746","journal-title":"J Cell Mol Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/ph15070879","volume":"15","author":"Xue N.","year":"2022","unstructured":"Xue N.; Ding X.; Huang R.; Bone tissue engineering in the treatment of bone defects. Pharmaceuticals  2022,15(7),879","journal-title":"Pharmaceuticals"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/230949900601400308","volume":"14","author":"Magadum M.P.","year":"2006","unstructured":"Magadum M.P.; Yadav C.M.B.; Phaneesha M.S.; Ramesh L.J.; Acute compression and lengthening by the Ilizarov technique for infected nonunion of the tibia with large bone defects. J Orthop Surg  2006,14(3),273-279","journal-title":"J Orthop Surg"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"025009","DOI":"10.1088\/1758-5090\/aa6725","volume":"9","author":"Kuznetsova D.","year":"2017","unstructured":"Kuznetsova D.; Ageykin A.; Koroleva A.; Surface micromorphology of cross-linked tetrafunctional polylactide scaffolds inducing vessel growth and bone formation. Biofabrication  2017,9(2),025009","journal-title":"Biofabrication"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/BOT.0000000000000977","volume":"31","author":"Tosounidis T.H.","year":"2017","unstructured":"Tosounidis T.H.; Giannoudis P.V.; Biological facet of segmental bone loss reconstruction. J Orthop Trauma  2017,31(5),S27-S31","journal-title":"J Orthop Trauma"},{"key":"ref=14","first-page":"143","volume":"23","author":"Mauffrey C.","year":"2015","unstructured":"Mauffrey C.; Barlow B.T.; Smith W.; Management of segmental bone defects. J Am Acad Orthop Surg  2015,23(3),143-153","journal-title":"J Am Acad Orthop Surg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jso.25309","volume":"119","author":"Ogink P.T.","year":"2019","unstructured":"Ogink P.T.; Teunissen F.R.; Massier J.R.; Raskin K.A.; Schwab J.H.; Lozano-Calderon S.A.; Allograft reconstruction of the humerus: Complications and revision surgery. J Surg Oncol  2019,119(3),329-335","journal-title":"J Surg Oncol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40824-019-0157-y","volume":"23","author":"Sohn H.S.","year":"2019","unstructured":"Sohn H.S.; Oh J.K.; Review of bone graft and bone substitutes with an emphasis on fracture surgeries. Biomater Res  2019,23(1),9","journal-title":"Biomater Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jconrel.2013.06.024","volume":"171","author":"Wada K.","year":"2013","unstructured":"Wada K.; Yu W.; Elazizi M.; Locally delivered salicylic acid from a poly(anhydride-ester): Impact on diabetic bone regeneration. J Control Release  2013,171(1),33-37","journal-title":"J Control Release"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1177\/0022034514547271","volume":"93","author":"Tevlin R.","year":"2014","unstructured":"Tevlin R.; McArdle A.; Atashroo D.; Biomaterials for craniofacial bone engineering. J Dent Res  2014,93(12),1187-1195","journal-title":"J Dent Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-4939-3584-0_2","volume":"1416","author":"Quarto R.","year":"2016","unstructured":"Quarto R.; Giannoni P.; Bone tissue engineering: Past-present-future. Methods Mol Biol  2016,1416,21-33","journal-title":"Methods Mol Biol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s10856-014-5240-2","volume":"25","author":"Campana V.","year":"2014","unstructured":"Campana V.; Milano G.; Pagano E.; Bone substitutes in orthopaedic surgery: From basic science to clinical practice. J Mater Sci Mater Med  2014,25(10),2445-2461","journal-title":"J Mater Sci Mater Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.injury.2006.02.040","volume":"37","author":"Soucacos P.N.","year":"2006","unstructured":"Soucacos P.N.; Dailiana Z.; Beris A.E.; Johnson E.O.; Vascularised bone grafts for the management of non-union. Injury  2006,37(S1),S41-S50","journal-title":"Injury"},{"key":"ref=22","author":"Junqueira L.C.","year":"2013","unstructured":"Junqueira L.C.; Mescher A.; Anthony L.;  Junqueira\u2019s basic histology: text and atlas\/Anthony L  2013","journal-title":"Junqueira\u2019s basic histology: text and atlas\/Anthony L"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2106\/00004623-199173090-00004","volume":"73","author":"Kim H.K.","year":"1991","unstructured":"Kim H.K.; Moran M.E.; Salter R.B.; The potential for regeneration of articular cartilage in defects created by chondral shaving and subchondral abrasion. An experimental investigation in rabbits. J Bone Joint Surg Am  1991,73(9),1301-1315","journal-title":"J Bone Joint Surg Am"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.addr.2006.01.012","volume":"58","author":"Nesic D.","year":"2006","unstructured":"Nesic D.; Whiteside R.; Brittberg M.; Wendt D.; Martin I.; Mainilvarlet P.; Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliv Rev  2006,58(2),300-322","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.47093\/2218-7332.2021.293.03","volume":"12","author":"Sadri B.","year":"2021","unstructured":"Sadri B.; Nouraein S.; Hossein-Khannazer N.; Mohammadi J.; Vosough M.; Current and novel theranostic modalities for knee osteoarthritis. Jour  2021,12(3),17-30","journal-title":"Jour"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms23052767","volume":"23","author":"Peshkova M.","year":"2022","unstructured":"Peshkova M.; Lychagin A.; Lipina M.; Gender-related aspects in osteoarthritis development and progression: A review. Int J Mol Sci  2022,23(5),2767","journal-title":"Int J Mol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/jars.2003.50112","volume":"19","author":"Steadman J.R.","year":"2003","unstructured":"Steadman J.R.; Briggs K.K.; Rodrigo J.J.; Kocher M.S.; Gill T.J.; Rodkey W.G.; Outcomes of microfracture for traumatic chondral defects of the knee: Average 11-year follow-up. Arthroscopy  2003,19(5),477-484","journal-title":"Arthroscopy"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/bmb\/ldn025","volume":"87","author":"Bhosale A.M.","year":"2008","unstructured":"Bhosale A.M.; Richardson J.B.; Articular cartilage: Structure, injuries and review of management. Br Med Bull  2008,87(1),77-95","journal-title":"Br Med Bull"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/0363546505274578","volume":"33","author":"Alford J.W.","year":"2005","unstructured":"Alford J.W.; Cole B.J.; Cartilage restoration, part 2: Techniques, outcomes, and future directions. Am J Sports Med  2005,33(3),443-460","journal-title":"Am J Sports Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.bjps.2009.06.003","volume":"63","author":"Neovius E.","year":"2010","unstructured":"Neovius E.; Engstrand T.; Craniofacial reconstruction with bone and biomaterials: Review over the last 11 years. J Plast Reconstr Aesthet Surg  2010,63(10),1615-1623","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/jps.21528","volume":"98","author":"Baroli B.","year":"2009","unstructured":"Baroli B.; From natural bone grafts to tissue engineering therapeutics: Brainstorming on pharmaceutical formulative requirements and challenges. J Pharm Sci  2009,98(4),1317-1375","journal-title":"J Pharm Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1749-799X-8-33","volume":"8","author":"Flierl M.A.","year":"2013","unstructured":"Flierl M.A.; Smith W.R.; Mauffrey C.; Outcomes and complication rates of different bone grafting modalities in long bone fracture nonunions: A retrospective cohort study in 182 patients. J Orthop Surg Res  2013,8(1),33","journal-title":"J Orthop Surg Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/bcpt.13478","volume":"128","author":"Wang X.","year":"2021","unstructured":"Wang X.; Thomsen P.; Mesenchymal stem cell-derived small extracellular vesicles and bone regeneration. Basic Clin Pharmacol Toxicol  2021,128(1),18-36","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/ijms24031836","volume":"24","author":"Zhou Z.","year":"2023","unstructured":"Zhou Z.; Zheng J.; Meng X.; Wang F.; Effects of electrical stimulation on articular cartilage regeneration with a focus on piezoelectric biomaterials for articular cartilage tissue repair and engineering. Int J Mol Sci  2023,24(3),1836","journal-title":"Int J Mol Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1056\/NEJM199410063311401","volume":"331","author":"Brittberg M.","year":"1994","unstructured":"Brittberg M.; Lindahl A.; Nilsson A.; Ohlsson C.; Isaksson O.; Peterson L.; Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med  1994,331(14),889-895","journal-title":"N Engl J Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.2106\/00004623-200710000-00002","volume":"89","author":"Knutsen G.","year":"2007","unstructured":"Knutsen G.; Isaksen V.; Johansen O.; A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am  2007,89(10),2105-2112","journal-title":"J Bone Joint Surg Am"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1177\/0363546511422220","volume":"39","author":"Vanlauwe J.","year":"2011","unstructured":"Vanlauwe J.; Saris D.B.F.; Victor J.; Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: Early treatment matters. Am J Sports Med  2011,39(12),2566-2574","journal-title":"Am J Sports Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/bioengineering6010022","volume":"6","author":"Davies R.","year":"2019","unstructured":"Davies R.; Kuiper N.; Regenerative medicine: A review of the evolution of autologous chondrocyte implantation (ACI) therapy. Bioengineering  2019,6(1),22","journal-title":"Bioengineering"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/267531a0","volume":"267","author":"Von Der Mark K.","year":"1977","unstructured":"Von Der Mark K.; Gauss V.; Von Der Mark H.; M\u00fcller P.; Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature  1977,267(5611),531-532","journal-title":"Nature"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/stem.1634","volume":"32","author":"Jo C.H.","year":"2014","unstructured":"Jo C.H.; Lee Y.G.; Shin W.H.; Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: A proof-of-concept clinical trial. Stem Cells  2014,32(5),1254-1266","journal-title":"Stem Cells"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"13796","DOI":"10.3390\/ijms232213796","volume":"23","author":"Peshkova M.","year":"2022","unstructured":"Peshkova M.; Kosheleva N.; Shpichka A.; Targeting inflammation and regeneration: Scaffolds, extracellular vesicles, and nanotechnologies as cell-free dual-target therapeutic strategies. Int J Mol Sci  2022,23(22),13796","journal-title":"Int J Mol Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1177\/0363546517716631","volume":"45","author":"Ogura T.","year":"2017","unstructured":"Ogura T.; Mosier B.A.; Bryant T.; Minas T.; A 20-year follow-up after first-generation autologous chondrocyte implantation. Am J Sports Med  2017,45(12),2751-2761","journal-title":"Am J Sports Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2106\/00004623-200603000-00006","volume":"88","author":"Wood J.J.","year":"2006","unstructured":"Wood J.J.; Malek M.A.; Frassica F.J.; Autologous cultured chondrocytes: Adverse events reported to the United States Food and Drug Administration. J Bone Joint Surg Am  2006,88(3),503-507","journal-title":"J Bone Joint Surg Am"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.injury.2008.01.040","volume":"39","author":"Brittberg M.","year":"2008","unstructured":"Brittberg M.; Autologous chondrocyte implantation-Technique and long-term follow-up. Injury  2008,39(S1),40-49","journal-title":"Injury"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/jor.1100180517","volume":"18","author":"Lee C.R.","year":"2000","unstructured":"Lee C.R.; Grodzinsky A.J.; Hsu H.P.; Martin S.D.; Spector M.; Effects of harvest and selected cartilage repair procedures on the physical and biochemical properties of articular cartilage in the canine knee. J Orthop Res  2000,18(5),790-799","journal-title":"J Orthop Res"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1177\/0363546509348477","volume":"37","author":"Gomoll A.H.","year":"2009","unstructured":"Gomoll A.H.; Probst C.; Farr J.; Cole B.J.; Minas T.; Use of a type I\/III bilayer collagen membrane decreases reoperation rates for symptomatic hypertrophy after autologous chondrocyte implantation. Am J Sports Med  2009,37(S1),20S-23S","journal-title":"Am J Sports Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.joca.2011.02.010","volume":"19","author":"Harris J.D.","year":"2011","unstructured":"Harris J.D.; Siston R.A.; Brophy R.H.; Lattermann C.; Carey J.L.; Flanigan D.C.; Failures, re-operations, and complications after autologous chondrocyte implantation \u2013 a systematic review. Osteoarthritis Cartilage  2011,19(7),779-791","journal-title":"Osteoarthritis Cartilage"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00064-008-1303-1","volume":"20","author":"Anders S.","year":"2008","unstructured":"Anders S.; Schaumburger J.; Schubert T.; Grifka J.; Behrens P.; Matrix-associated autologous chondrocyte transplantation (MACT). Minimally invasive technique in the knee. Oper Orthop Traumatol  2008,20(3),208-219","journal-title":"Oper Orthop Traumatol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/00003086-200005000-00020","author":"Peterson L.","year":"2000","unstructured":"Peterson L.; Minas T.; Brittberg M.; Nilsson A.; Sj\u00f6gren-Jansson E.; Lindahl A.; Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res  2000(374),212-234","journal-title":"Clin Orthop Relat Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1359\/jbmr.2002.17.8.1420","volume":"17","author":"Anderer U.","year":"2002","unstructured":"Anderer U.; Libera J.; In vitro engineering of human autogenous cartilage. J Bone Miner Res  2002,17(8),1420-1429","journal-title":"J Bone Miner Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2325967119841077","DOI":"10.1177\/2325967119841077","volume":"7","author":"Hoburg A.","year":"2019","unstructured":"Hoburg A.; L\u00f6er I.; K\u00f6rsmeier K.; Matrix-associated autologous chondrocyte implantation is an effective treatment at midterm follow-up in adolescents and young adults. Orthop J Sports Med  2019,7(4),2325967119841077","journal-title":"Orthop J Sports Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.5966\/sctm.2016-0157","volume":"6","author":"Park Y.B.","year":"2017","unstructured":"Park Y.B.; Ha C.W.; Lee C.H.; Yoon Y.C.; Park Y.G.; Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood-derived mesenchymal stem cells and hyaluronate hydrogel: Results from a clinical trial for safety and proof-of-concept with 7 years of extended follow-up. Stem Cells Transl Med  2017,6(2),613-621","journal-title":"Stem Cells Transl Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2325967120973052","DOI":"10.1177\/2325967120973052","volume":"9","author":"Lim H.C.","year":"2021","unstructured":"Lim H.C.; Park Y.B.; Ha C.W.; Allogeneic umbilical cord blood-derived mesenchymal stem cell implantation versus microfracture for large, full-thickness cartilage defects in older patients: A multicenter randomized clinical trial and extended 5-year clinical follow-up. Orthop J Sports Med  2021,9(1),2325967120973052","journal-title":"Orthop J Sports Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/gels8020090","volume":"8","author":"Amr M.","year":"2022","unstructured":"Amr M.; Mallah A.; Yasmeen S.; From chondrocytes to chondrons, maintenance of phenotype and matrix production in a composite 3D hydrogel scaffold. Gels  2022,8(2),90","journal-title":"Gels"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/S0020-1383(13)70011-1","volume":"44","author":"Homma Y.","year":"2013","unstructured":"Homma Y.; Zimmermann G.; Hernigou P.; Cellular therapies for the treatment of non-union: The past, present and future. Injury  2013,44(S1),S46-S49","journal-title":"Injury"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.pmrj.2015.01.023","volume":"7","author":"Sampson S.","year":"2015","unstructured":"Sampson S.; Bemden A.; Aufiero D.; Stem cell therapies for treatment of cartilage and bone disorders: osteoarthritis, avascular necrosis, and non-union fractures. PM R  2015,7(4S),S26-S32","journal-title":"PM R"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"R589","DOI":"10.1016\/S0960-9822(01)00359-1","volume":"11","author":"White A.","year":"2001","unstructured":"White A.; Wallis G.; Endochondral ossification: A delicate balance between growth and mineralisation. Curr Biol  2001,11(15),R589-R591","journal-title":"Curr Biol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2010.07.010","volume":"19","author":"Maes C.","year":"2010","unstructured":"Maes C.; Kobayashi T.; Selig M.K.; Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell  2010,19(2),329-344","journal-title":"Dev Cell"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.22203\/eCM.v015a08","volume":"15","author":"Kanczler J.M.","year":"2008","unstructured":"Kanczler J.M.; Oreffo R.O.C.; Osteogenesis and angiogenesis: The potential for engineering bone. Eur Cell Mater  2008,15,100-114","journal-title":"Eur Cell Mater"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.injury.2011.03.031","volume":"42","author":"Marsell R.","year":"2011","unstructured":"Marsell R.; Einhorn T.A.; The biology of fracture healing. Injury  2011,42(6),551-555","journal-title":"Injury"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.orthres.2005.01.013","volume":"23","author":"Shirley D.","year":"2005","unstructured":"Shirley D.; Marsh D.; Jordan G.; McQuaid S.; Li G.; Systemic recruitment of osteoblastic cells in fracture healing. J Orthop Res  2005,23(5),1013-1021","journal-title":"J Orthop Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1089\/scd.2014.0490","volume":"24","author":"Todeschi M.R.","year":"2015","unstructured":"Todeschi M.R.; El Backly R.; Capelli C.; Transplanted umbilical cord mesenchymal stem cells modify the in vivo microenvironment enhancing angiogenesis and leading to bone regeneration. Stem Cells Dev  2015,24(13),1570-1581","journal-title":"Stem Cells Dev"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","volume":"9","author":"Caplan A.I.","year":"2011","unstructured":"Caplan A.I.; Correa D.; The MSC: an injury drugstore. Cell Stem Cell  2011,9(1),11-15","journal-title":"Cell Stem Cell"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12929-021-00725-7","volume":"28","author":"Zhuang W.Z.","year":"2021","unstructured":"Zhuang W.Z.; Lin Y.H.; Su L.J.; Mesenchymal stem\/stromal cell-based therapy: Mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci  2021,28(1),28","journal-title":"J Biomed Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"Song N.","year":"2020","unstructured":"Song N.; Scholtemeijer M.; Shah K.; Mesenchymal stem cell immunomodulation: Mechanisms and therapeutic potential. Trends Pharmacol Sci  2020,41(9),653-664","journal-title":"Trends Pharmacol Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/980353","volume":"2012","author":"Zomorodian E.","year":"2012","unstructured":"Zomorodian E.; Eslaminejad B.M.; Mesenchymal stem cells as a potent cell source for bone regeneration. Stem Cells Int  2012,2012,1-9","journal-title":"Stem Cells Int"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/stem.103","volume":"27","author":"Granero-Molt\u00f3 F.","year":"2009","unstructured":"Granero-Molt\u00f3 F.; Weis J.A.; Miga M.I.; Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells  2009,27(8),1887-1898","journal-title":"Stem Cells"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/03008207.2022.2074841","volume":"63","author":"Sadri B.","year":"2022","unstructured":"Sadri B.; Tamimi A.; Nouraein S.; Clinical and laboratory findings following transplantation of allogeneic adipose-derived mesenchymal stromal cells in knee osteoarthritis, a brief report. Connect Tissue Res  2022,63(6),663-674","journal-title":"Connect Tissue Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00264-016-3130-6","volume":"40","author":"Wittig O.","year":"2016","unstructured":"Wittig O.; Romano E.; Gonz\u00e1lez C.; A method of treatment for nonunion after fractures using mesenchymal stromal cells loaded on collagen microspheres and incorporated into platelet-rich plasma clots. Int Orthop  2016,40(5),1033-1038","journal-title":"Int Orthop"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.injury.2021.09.061","volume":"53","author":"Marchan J.","year":"2022","unstructured":"Marchan J.; Wittig O.; Diaz-Solano D.; Gomez M.; Cardier J.E.; Enhanced chondrogenesis from chondrocytes co-cultured on mesenchymal stromal cells: Implication for cartilage repair. Injury  2022,53(2),399-407","journal-title":"Injury"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/jor.22028","volume":"30","author":"Gao C.","year":"2012","unstructured":"Gao C.; Seuntjens J.; Kaufman G.N.; Mesenchymal stem cell transplantation to promote bone healing. J Orthop Res  2012,30(8),1183-1189","journal-title":"J Orthop Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/bcp.12382","volume":"78","author":"Liao Y.","year":"2014","unstructured":"Liao Y.; Zhang X.L.; Li L.; Shen F.M.; Zhong M.K.; Stem cell therapy for bone repair: A systematic review and meta-analysis of preclinical studies with large animal models. Br J Clin Pharmacol  2014,78(4),718-726","journal-title":"Br J Clin Pharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1759720X16642372","volume":"8","author":"Jones E.A.","year":"2016","unstructured":"Jones E.A.; Giannoudis P.V.; Kouroupis D.; Bone repair with skeletal stem cells: Rationale, progress to date and clinical application. Ther Adv Musculoskelet Dis  2016,8(3),57-71","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1302\/2633-1462.110.BJO-2020-0129","volume":"1","author":"Mott A.","year":"2020","unstructured":"Mott A.; Mitchell A.; McDaid C.; Systematic review assessing the evidence for the use of stem cells in fracture healing. Bone and Joint Open  2020,1(10),628-638","journal-title":"Bone and Joint Open"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2174\/1574888X12666170915121137","volume":"13","author":"Killington K.","year":"2018","unstructured":"Killington K.; Mafi R.; Mafi P.; Khan W.S.; A systematic review of clinical studies investigating mesenchymal stem cells for fracture non-union and bone defects. Curr Stem Cell Res Ther  2018,13(4),284-291","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/sctm.18-0053","volume":"8","author":"Matas J.","year":"2019","unstructured":"Matas J.; Orrego M.; Amenabar D.; Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: Repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I\/II trial: Umbilical cord MSC for knee osteoarthritis. Stem Cells Transl Med  2019,8(3),215-224","journal-title":"Stem Cells Transl Med"},{"key":"ref=77","first-page":"343","volume":"11","author":"Centeno C.J.","year":"2008","unstructured":"Centeno C.J.; Busse D.; Kisiday J.; Keohan C.; Freeman M.; Karli D.; Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician  2008,11(3),343-353","journal-title":"Pain Physician"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13287-021-02689-9","volume":"13","author":"Xiang X.N.","year":"2022","unstructured":"Xiang X.N.; Zhu S.Y.; He H.C.; Yu X.; Xu Y.; He C.Q.; Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis. Stem Cell Res Ther  2022,13(1),14","journal-title":"Stem Cell Res Ther"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.arthro.2018.07.028","volume":"35","author":"Ha C.W.","year":"2019","unstructured":"Ha C.W.; Park Y.B.; Kim S.H.; Lee H.J.; Intra-articular mesenchymal stem cells in osteoarthritis of the knee: A systematic review of clinical outcomes and evidence of cartilage repair. Arthroscopy  2019,35(1),277-288.e2","journal-title":"Arthroscopy"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.joca.2014.06.035","volume":"22","author":"Lam J.","year":"2014","unstructured":"Lam J.; Lu S.; Lee E.J.; Osteochondral defect repair using bilayered hydrogels encapsulating both chondrogenically and osteogenically pre-differentiated mesenchymal stem cells in a rabbit model. Osteoarthritis Cartilage  2014,22(9),1291-1300","journal-title":"Osteoarthritis Cartilage"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/jor.21413","volume":"29","author":"Dashtdar H.","year":"2011","unstructured":"Dashtdar H.; Rothan H.A.; Tay T.; A preliminary study comparing the use of allogenic chondrogenic pre-differentiated and undifferentiated mesenchymal stem cells for the repair of full thickness articular cartilage defects in rabbits. J Orthop Res  2011,29(9),1336-1342","journal-title":"J Orthop Res"},{"key":"ref=82","first-page":"1031","volume":"16","author":"Ramezanifard R.","year":"2017","unstructured":"Ramezanifard R.; Kabiri M.; Ahvaz H.; Effects of platelet rich plasma and chondrocyte co-culture on MSC chondrogenesis, hypertrophy and pathological responses. EXCLI J  2017,16,1031-1045","journal-title":"EXCLI J"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2147\/DDDT.S356936","volume":"16","author":"Gu J.","year":"2022","unstructured":"Gu J.; Wang B.; Wang T.; Effects of cartilage progenitor cells, bone marrow mesenchymal stem cells and chondrocytes on cartilage repair as seed cells: An in vitro study. Drug Des Devel Ther  2022,16,1217-1230","journal-title":"Drug Des Devel Ther"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.1002\/jcp.29615","volume":"235","author":"Zhi Z.","year":"2020","unstructured":"Zhi Z.; Zhang C.; Kang J.; The therapeutic effect of bone marrow\u2013derived mesenchymal stem cells on osteoarthritis is improved by the activation of the KDM6A\/SOX9 signaling pathway caused by exposure to hypoxia. J Cell Physiol  2020,235(10),7173-7182","journal-title":"J Cell Physiol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/0363546520988069","volume":"49","author":"Saris T.F.F.","year":"2021","unstructured":"Saris T.F.F.; de Windt T.S.; Kester E.C.; Vonk L.A.; Custers R.J.H.; Saris D.B.F.; Five-year outcome of 1-stage cell-based cartilage repair using recycled autologous chondrons and allogenic mesenchymal stromal cells: A first-in-human clinical trial. Am J Sports Med  2021,49(4),941-947","journal-title":"Am J Sports Med"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1186\/s13063-020-04771-8","volume":"21","author":"Korpershoek J.V.","year":"2020","unstructured":"Korpershoek J.V.; Vonk L.A.; Kester E.C.; Efficacy of one-stage cartilage repair using allogeneic mesenchymal stromal cells and autologous chondron transplantation (IMPACT) compared to nonsurgical treatment for focal articular cartilage lesions of the knee: Study protocol for a crossover randomized controlled trial. Trials  2020,21(1),842","journal-title":"Trials"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2217\/rme-2017-0032","volume":"12","author":"Richardson J.B.","year":"2017","unstructured":"Richardson J.B.; Wright K.T.; Wales J.; Efficacy and safety of autologous cell therapies for knee cartilage defects (autologous stem cells, chondrocytes or the two): Randomized controlled trial design. Regen Med  2017,12(5),493-501","journal-title":"Regen Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/bioengineering9030111","volume":"9","author":"Muthu S.","year":"2022","unstructured":"Muthu S.; Jeyaraman M.; Kotner M.B.; Evolution of mesenchymal stem cell therapy as an Advanced Therapeutic Medicinal Product (ATMP)-an Indian perspective. Bioengineering  2022,9(3),111","journal-title":"Bioengineering"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3389\/fphar.2019.00921","volume":"10","author":"Iglesias-L\u00f3pez C.","year":"2019","unstructured":"Iglesias-L\u00f3pez C.; Agust\u00ed A.; Obach M.; Vallano A.; Regulatory framework for advanced therapy medicinal products in Europe and United States. Front Pharmacol  2019,10,921","journal-title":"Front Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s40778-015-0012-6","volume":"1","author":"Azuma K.","year":"2015","unstructured":"Azuma K.; Regulatory landscape of regenerative medicine in japan. Curr Stem Cell Rep  2015,1(2),118-128","journal-title":"Curr Stem Cell Rep"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26633\/RPSP.2021.10","volume":"45","author":"Dur\u00e1n C.E.","year":"2021","unstructured":"Dur\u00e1n C.E.; Ca\u00f1\u00e1s M.; Urtasun M.A.; Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries. Rev Panam Salud Publica  2021,45,1-10","journal-title":"Rev Panam Salud Publica"},{"key":"ref=92","unstructured":"Courageous Innovation  Available from: https:\/\/www.raps.org\/regulatory-focus\/news-articles\/2015\/4\/the-essential-list-of-regulatory-authorities-in-asia#"},{"key":"ref=93","unstructured":"Verified Clinical Benefit | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals.  Available from:  https:\/\/www.fda.gov\/drugs\/accelerated-approval-program\/verified-clinical-benefit-non-malignant-hematological-neurological-and-other-disorder-indications"},{"key":"ref=94","unstructured":"Vericel Initiates Collaboration with Innovative Cellular Therapeutics.   Available from:   https:\/\/investors.vcel.com\/news-releases\/news-release-details\/vericel-initiates-collaboration-innovative-cellular-therapeutics"},{"key":"ref=95","unstructured":"ChondroCelect RSS.  Available from: \n https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/chondrocelect"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0363546507311095","volume":"36","author":"Saris D.B.F.","year":"2008","unstructured":"Saris D.B.F.; Vanlauwe J.; Victor J.; Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med  2008,36(2),235-246","journal-title":"Am J Sports Med"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1177\/0363546509350694","volume":"37","author":"Saris D.B.F.","year":"2009","unstructured":"Saris D.B.F.; Vanlauwe J.; Victor J.; Almqvist K.F.; Verdonk R.; Bellemans J.; Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture: Characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med  2009,37(S1),10S-19S","journal-title":"Am J Sports Med"},{"key":"ref=98","unstructured":"MACI (Autologous Cultured Chondrocytes on a Porcine Collagen Membrane).   Available from:\n https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/maci-autologous-cultured-chondrocytes-porcine-collagen-membrane"},{"key":"ref=99","unstructured":"Maci.  Available from: \n https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/maci"},{"key":"ref=100","unstructured":"A country where medicines are safe.  Available from:\n https:\/\/nedrug.mfds.go.kr"},{"key":"ref=101","unstructured":"Products.  Available from:\n https:\/\/www.mfds.go.kr\/eng\/brd\/m_19\/list.do"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2474-11-103","volume":"11","author":"Choi N-Y.","year":"2010","unstructured":"Choi N-Y.; Kim B-W.; Yeo W-J.; Kim H-B.; Suh D-S.; Kim J-S.; Gel-type autologous chondrocyte (Chondron) implantation for treatment of articular cartilage defects of the knee. BMC Musculoskelet Disord  2010,11,103","journal-title":"BMC Musculoskelet Disord"},{"key":"ref=103","unstructured":"For patients.  Available from: \n https:\/\/www.regrow.in\/cartigrow-for-cartilage-damage"},{"key":"ref=104","unstructured":"Review Reports: Regenerative Medical Products.   Available from: \n https:\/\/www.pmda.go.jp\/english\/review-services\/reviews\/approved-information\/0004.html"},{"key":"ref=105","unstructured":"Spherox.  Available from: \n https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spherox"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s40273-018-0737-z","volume":"37","author":"Armoiry X.","year":"2019","unstructured":"Armoiry X.; Cummins E.; Connock M.; Autologous chondrocyte implantation with Chondrosphere for treating articular cartilage defects in the knee: An evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics  2019,37(7),879-886","journal-title":"PharmacoEconomics"},{"key":"ref=107","unstructured":"Cellular Therapies - Chondrocytes - T - Ortho-ACI - Orthocell Ltd - Suspension - Vial (289402).  Available from: \n https:\/\/www.tga.gov.au\/resources\/artg\/289402"},{"key":"ref=108","year":"2022","unstructured":"Regeneration of human cartilage.  Available from: \n https:\/\/orthocell.com\/orthoaci2022"},{"key":"ref=109","unstructured":"Aesculap biologics, LLC.   Available from:\n https:\/\/www. aesculapbiologics.com"},{"key":"ref=110","unstructured":"Mesestrocell- Cell therapy for osteoarthritis.  Available from: \n http:\/\/en.celltech.ir\/mesestrocell-cell-therapy-for-osteoarthritis\/"},{"key":"ref=111","unstructured":"Mfds.go.kr.  Available from:\n https:\/\/www.mfds.go.kr\/eng\/brd\/m_30\/view.do?seq=70954"},{"key":"ref=112","unstructured":"OSSGROW - for patients.  Available from:\n https:\/\/www. ossgrow.com"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrd3052","volume":"9","author":"Schneider C.K.","year":"2010","unstructured":"Schneider C.K.; Salmikangas P.; Jilma B.; Challenges with advanced therapy medicinal products and how to meet them. Nat Rev Drug Discov  2010,9(3),195-201","journal-title":"Nat Rev Drug Discov"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"41","DOI":"10.52198\/22.STI.41.OS1613","volume":"41","author":"Grossman A.D.","year":"2022","unstructured":"Grossman A.D.; Den Haese J.P.; Georger L.; Mc Millan S.; Tuck J.A.; Matrix-induced Autologous Chondrocyte Implantation (MACI) is largely effective and provides significant improvement in patients with symptomatic, large chondral defects: A systematic review and meta-analysis. Surg Technol Int  2022,41,41","journal-title":"Surg Technol Int"},{"key":"ref=115","year":"2022","unstructured":"Ocugen inc. - patient-centric biotechnology   Available from:\n https:\/\/ocugen.com2022"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2217\/rme-2017-0152","volume":"13","author":"Song Y.","year":"2018","unstructured":"Song Y.; Du H.; Dai C.; Human adipose-derived mesenchymal stem cells for osteoarthritis: A pilot study with long-term follow-up and repeated injections. Regen Med  2018,13(3),295-307","journal-title":"Regen Med"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2217\/rme-2019-0068","volume":"15","author":"Qiao Z.","year":"2020","unstructured":"Qiao Z.; Tang J.; Yue B.; Human adipose-derived mesenchymal progenitor cells plus microfracture and hyaluronic acid for cartilage repair: A Phase IIa trial. Regen Med  2020,15(1),1193-1214","journal-title":"Regen Med"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13287-019-1248-3","volume":"10","author":"Lu L.","year":"2019","unstructured":"Lu L.; Dai C.; Zhang Z.; Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: A prospective, randomized, double-blind, active-controlled, phase IIb clinical trial. Stem Cell Res Ther  2019,10(1),143","journal-title":"Stem Cell Res Ther"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13075-016-1195-7","volume":"18","author":"Gupta P.K.","year":"2016","unstructured":"Gupta P.K.; Chullikana A.; Rengasamy M.; Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel\u00ae): Preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther  2016,18(1),301","journal-title":"Arthritis Res Ther"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/s13287-021-02631-z","volume":"12","author":"Chen C.F.","year":"2021","unstructured":"Chen C.F.; Hu C.C.; Wu C.T.; Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE\u00ae: A phase I\/II, randomized, active-control, single-blind, multiple-center clinical trial. Stem Cell Res Ther  2021,12(1),562","journal-title":"Stem Cell Res Ther"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"S212","DOI":"10.1016\/j.joca.2019.02.330","volume":"27","author":"Lew S.","year":"2019","unstructured":"Lew S.; Cho J.; Kim T.; Lee M.; Long-term follow-up assessment of the safety and efficacy of INVOSSA-K INJ., a novel cell mediated gene therapy for treatment of osteoarthritis. Osteoarthritis Cartilage  2019,27,S212","journal-title":"Osteoarthritis Cartilage"},{"key":"ref=122","first-page":"e2022099","volume":"93","author":"Talesa G.","year":"2022","unstructured":"Talesa G.; Manfreda F.; Pace V.; The treatment of knee cartilage lesions: State of the art. Acta Biomed  2022,93(4),e2022099","journal-title":"Acta Biomed"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13287-021-02432-4","volume":"12","author":"Jayankura M.","year":"2021","unstructured":"Jayankura M.; Schulz A.P.; Delahaut O.; Percutaneous administration of allogeneic bone-forming cells for the treatment of delayed unions of fractures: A pilot study. Stem Cell Res Ther  2021,12(1),363","journal-title":"Stem Cell Res Ther"}],"container-title":["Current Reviews in Clinical and Experimental Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127724328274436231207062008","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/226048\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127724328274436231207062008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T11:48:06Z","timestamp":1717674486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/226048\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":123,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0127724328274436231207062008","relation":{},"ISSN":["2772-4328"],"issn-type":[{"value":"2772-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-07-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}